Open Call Offers Funded Services in Nanopharmaceutical Development
PHOENIX-OITB has extended the deadline for its Open Call, offering funded services in nanopharmaceutical development to a broad audience. The services and expertise provided by the PHOENIX-OITB include production and characterisation under GMP conditions, safety evaluation, regulatory compliance and commercialisation boost. Under the scope of the Open Call, following service categories are offered:
- Physico-Chemical Characterization,
- In vitro Characterisation,
- In vivo Characterisation and
Any legal entity (SMEs, start up or RTOs) and research group, based in the European Union or associate countries of H2020 can apply to this call.
First-stage applications are now due 28 February 2023.
To view the complete call and download all application documents, visit the dedicated Open Call page on the PHOENIX-OITB website below.
Go to open call